Navigation Links
NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidates
Date:7/22/2009

Scientists in a network of medical research institutions across the United States are set to begin a series of clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines. The research will be under the direction of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

"With the emergence of the 2009 H1N1 influenza virus, we have undertaken a collaborative and efficient process of vaccine development that is proceeding in stepwise fashion," says NIAID Director Anthony S. Fauci, M.D.

After the isolation and characterization of the virus, the U. S. Centers for Disease Control and Prevention generated and distributed a 2009 H1N1 seed virus to vaccine manufacturers for the development of vaccine pilot lots for testing in clinical trials.

"Now, NIAID will use our longstanding vaccine clinical trials infrastructurethe Vaccine and Treatment Evaluation Unitsto help quickly evaluate these pilot lots to determine whether the vaccines are safe and to assess their ability to induce protective immune responses," says Dr. Fauci. "These data will be factored into the decision about how and if to implement a 2009 H1N1 flu immunization program this fall."

Initial studies will look at whether one or two 15 microgram doses of H1N1 vaccine are needed to induce a potentially protective immune response in healthy adult volunteers (aged 18 to 64 years old) and elderly people (aged 65 and older). Researchers also will assess whether one or two 30 microgram doses are needed. The doses will be given 21 days apart, testing two manufacturers' vaccines (Sanofi Pasteur and CSL Biotherapies). If early information from those trials indicates that these vaccines are safe, similar trials in healthy children (aged 6 months to 17 years old) will begin.

A concurrent set of trials will look at the safety and immune response in healthy adult and eld
'/>"/>

Contact: Anne A. Oplinger
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine
2. J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases
3. NIAID and Chinese officials sign agreement to foster TB research in Chinas Henan province
4. NIAID honors AIDS activist Martin Delaney
5. NIAID media availability: Seizures following parasitic infection associated with brain swelling
6. NIAID awards contracts to search for protein markers of disease
7. NIAID creates HIV vaccine discovery branch
8. NIAID to advance B-cell approach to HIV vaccines
9. NIAID describes research priorities to fight drug-resistant tuberculosis
10. NIAID to convene HIV Vaccine Summit
11. NIAID scientists identify new cellular receptor for HIV

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...m The Healy Law Firm secure the highest pool-relat...endered an incomplete quadriplegic. , ..., 2009 -- A Cook County jury has entered an $8.1 m...enter, 22 years old at the time, who dove into a s...plegic. The verdict, which was reduced to $4,051,...
(Date:11/30/2009)...(NASDAQ OMX Copenhagen: “EXQ”) announc...wood Screening Facility (ICCB-L) has been recogniz...ICCB-L supports investigators at Harvard Medical S...for high-throughput screening of small molecule an...n, MA and Copenhagen, Denmark (PRWEB) November 30,...
(Date:11/30/2009)...vember 30 Simbionix USA Corporatio...tion systems, in collaboration,with GORE Medical P...dio(TM),workshop for the first time at the upcomin...he Simbionix PROcedure Rehearsal Studio(TM) is the...ans to create practice scenarios based on their,pa...
(Date:11/30/2009)... revealed that beverage can pull-tabs were being s...anufacturers to stay-tabs. But a study presented t...iety of North America (RSNA) found that the new ta...riving factors leading the change in beverage can ...ent swallowing of the pull-tab and potential relat...
(Date:11/30/2009)...stern Medical Center researchers have found that i...ations associated with asthma. The findings, avail...cs, suggest that interventions by parent mentors ...d specialized topical training can effectively re...ts and missed adult workdays. , "Childhood asthm...
Breaking Medicine News(10 mins):Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 2Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 3Health News:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Health News:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Health News:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 4Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3Health News:Beverage can stay-tabs pose swallowing risk 2Health News:Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find 2
...aries widely from state to state, with some states...stroke prevalence of others , according to a new r...vention (CDC). The report, "Prevalence of Stroke -...0 states, the District of Columbia and U.S. territ...
...n Malloy, critically injured in a car accident, sk...l her story. Doctors call her recovery a miracle....Her skull separated from her spine, although her s...ontrol over her head. Surgeons said her injur...
...am of researchers from the University of East Angl...-Planck Institute for Biogeochemistry have found ...rbon dioxide has reached a saturation point. ...has led to a release of stored CO2 into the atmosp...
...tandard regimen in most cancer treatments. Since i...re made to replace it with something more comfort...that LHRH agonists like the drug Zoladex switch of...king the action of a naturally occurring substance...
...as found that intake of cruciferous vegetables wit...otective benefit against bladder cancer. ...ciferous vegetables such as broccoli, cauliflower,...on of cytochrome p450 enzyme levels and provoke ap...
...ly affects to work, sleep and performance of other...r your memory and your concentration. Thi...nd Saifudin Rashiq at the University of Alberta. ...tients, two-thirds of whom showed significant disr...
Other Medicine News:Health News:Significant Differences in Stroke Prevalence Among U.S. States & Territories - CDC Report 2Health News:30-year-old Woman Survives 'internal Decapitation' 2Health News:A Fresh Alternative to Painful Chemotherapy Developed in UK 2Health News:Risk of Bladder Cancer Reduced by Broccoli and Cauliflower 2Health News:Chronic Pain can Impair Memory and Concentration 2
(Date:11/29/2009)..., , CHICAGO, Nov. 29 A...g of the Radiological Society of North America (RS...ace in Chicago , Siemens Healthcare will introduc...ventional oncology at booth #825, East Building/...ly invasive procedures for cancer therapy, the...
(Date:11/29/2009)..., , IOWA CITY, Iowa and ST. LOUIS, Nov. 2...loper of quantitative imaging software for the adv...dical Technologies, a leader in minimally invasive...nounced the companies have signed a definitive agr... of an endobronchial lung navigation and biopsy sy...
(Date:11/29/2009)..., , CHICAGO, Nov. 29 Stimula...ket leadership Fujifilm Medical Systems USA announ...erica (RSNA) annual meeting, the formation of its ... Networks Systems, this new group will integrate a...tics offering and creates a platform for future gr...
Breaking Medicine Technology:Minimally Invasive Procedure for Oncology 2Minimally Invasive Procedure for Oncology 3Minimally Invasive Procedure for Oncology 4Minimally Invasive Procedure for Oncology 5VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 2VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 4FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 1Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 2Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 3Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 4MRI Might Find Early Alzheimers 55180 1MRI Might Find Early Alzheimers 55180 2Trust in a teardrop 9687 1Trust in a teardrop 9687 2
...TON, N.J., March 25, 2007 /PRNewswire/ -- Once-dai...ation tolvaptan, a,vasopressin receptor antagonist...mptoms of acutely decompensated heart failure (ADH... care, without an,adverse effect on their long-ter...the short- and long-term analyses of the,internati...
...leeding in Patients Treated for Acute Coronary Syn...ne Year, NEW ORLEANS, March 26, 2007 /PRNewswire/ ...l show that acute coronary syndrome,(ACS) patients...t,group had similar rates of ischemic clinical out...apy, confirming previous findings,which showed si...
Other Medicine Technology:Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 2Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 3Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 4Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 6Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 7Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 2Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 3Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 4Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 5Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 6
Protector Collar
Serpentine Cervical Collar
...ipital Mandibular Immobilizer) A completely adjust...ral or hypertension positioning and immobilization...™ collar and a halo-type brace.,Mandibular ...ovable chin plate allows for patient eating and hy...
Ezy Wrap® Economy Contour Cervical Collar
Medicine Products: